(PDF) The Efficacy and Safety of Combination of PD-1 and

The Efficacy and Safety of Combination of PD-1 and CTLA-4 Inhibitors: A Meta-Analysis

Experimental Hematology and Oncology - United Kingdom

doi 10.1186/s40164-019-0150-0

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

October 25, 2019

Authors

Publisher

Springer Science and Business Media LLC

Related search

The Safety and Tolerability of Combined Immune Checkpoint Inhibitors (Anti-Pd-1/Pd-L1 Plus Anti-Ctla-4): A Systematic Review and Meta-Analysis

Cancer Research

English

Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing

Frontiers in Oncology

Cancer Research

English

Efficacy and Safety of Angiogenesis Inhibitors in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis

Journal of Hematology and Oncology

Cancer Research

Molecular Biology

English

CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers

International Journal of Endocrinology

Autonomic Systems

English

The Efficacy and Potential Predictive Factors of PD-1/PD-L1 Blockades in Epithelial Carcinoma Patients: A Systematic Review and Meta Analysis

English

Association Between the CTLA-4 +49a/G Polymorphism and Graves’ Disease: A Meta-Analysis

Experimental and Therapeutic Medicine

Cancer Research

English

The Safety and Efficacy of Approaches to Liver Resection: A Meta-Analysis

Journal of the Society of Laparoendoscopic Surgeons

English

Systematic Review and Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Intestinal Microbiota Predict Response and Toxicities During Anti-Pd-1/Anti-Ctla-4 Immunotherapy

Forensic Medicine

English